{
 "drug": "Methylphenidate Hydrochloride Tablet, Extended Release",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "07/26/2023",
 "dayN": 1126,
 "cat": "Psychiatry",
 "companies": [
  "Vertical Pharmaceuticals, LLC",
  "Teva Pharmaceuticals USA, Inc.",
  "Janssen Pharmaceuticals",
  "Lannett Company, Inc.",
  "Trigen Laboratories, LLC",
  "Sun Pharmaceutical Industries, Inc."
 ],
 "reasons": [
  "Other",
  "Demand increase for the drug",
  "Discontinuation of the manufacture of the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-088-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-097-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-097",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62037-726-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-545-8800",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "ANDA076772"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "62037-726",
     "62037-725",
     "62037-734",
     "62037-727"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210"
    ],
    "spl_id": [
     "24aa9277-3773-489d-8459-f9215140c53f"
    ],
    "spl_set_id": [
     "85ef422d-af27-4126-9841-6892af1871d6"
    ],
    "package_ndc": [
     "62037-725-01",
     "62037-734-01",
     "62037-726-01",
     "62037-727-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "50458-587-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021121"
    ],
    "brand_name": [
     "CONCERTA"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-587",
     "50458-585",
     "50458-588",
     "50458-586"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091157",
     "1091170",
     "1091172",
     "1091185",
     "1091187",
     "1091210",
     "1091212"
    ],
    "spl_id": [
     "64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"
    ],
    "spl_set_id": [
     "1a88218c-5b18-4220-8f56-526de1a276cd"
    ],
    "package_ndc": [
     "50458-585-01",
     "50458-588-01",
     "50458-586-01",
     "50458-587-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62175-310-37",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA091695"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "62175-310",
     "62175-311",
     "62175-312",
     "62175-313"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2001564",
     "2001565",
     "2001566",
     "2001568"
    ],
    "spl_id": [
     "8b133cd2-e3c6-4742-b402-2393b56ffc93"
    ],
    "spl_set_id": [
     "3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"
    ],
    "package_ndc": [
     "62175-310-37",
     "62175-311-37",
     "62175-312-37",
     "62175-313-37"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-710-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "ANDA205327"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-710",
     "13811-709",
     "13811-706",
     "13811-707",
     "13811-708"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461"
    ],
    "spl_id": [
     "0944cf70-d59a-483b-9698-e96ef955a65a"
    ],
    "spl_set_id": [
     "c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"
    ],
    "package_ndc": [
     "13811-709-10",
     "13811-706-10",
     "13811-707-10",
     "13811-708-10",
     "13811-710-10",
     "13811-710-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "50458-588-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021121"
    ],
    "brand_name": [
     "CONCERTA"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-588",
     "50458-585",
     "50458-586",
     "50458-587"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091157",
     "1091170",
     "1091172",
     "1091185",
     "1091187",
     "1091210",
     "1091212"
    ],
    "spl_id": [
     "64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"
    ],
    "spl_set_id": [
     "1a88218c-5b18-4220-8f56-526de1a276cd"
    ],
    "package_ndc": [
     "50458-585-01",
     "50458-588-01",
     "50458-586-01",
     "50458-587-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "57664-606-88",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-818-4555",
   "availability": "Unavailable",
   "related_info": "Currently not marketed",
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-709-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "ANDA205327"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-709",
     "13811-706",
     "13811-707",
     "13811-708",
     "13811-710"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461"
    ],
    "spl_id": [
     "0944cf70-d59a-483b-9698-e96ef955a65a"
    ],
    "spl_set_id": [
     "c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"
    ],
    "package_ndc": [
     "13811-709-10",
     "13811-706-10",
     "13811-707-10",
     "13811-708-10",
     "13811-710-10",
     "13811-710-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-089-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-089",
     "68025-088",
     "68025-095",
     "68025-096",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-707-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "ANDA205327"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-707",
     "13811-709",
     "13811-706",
     "13811-708",
     "13811-710"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461"
    ],
    "spl_id": [
     "0944cf70-d59a-483b-9698-e96ef955a65a"
    ],
    "spl_set_id": [
     "c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"
    ],
    "package_ndc": [
     "13811-709-10",
     "13811-706-10",
     "13811-707-10",
     "13811-708-10",
     "13811-710-10",
     "13811-710-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-096-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-096",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62037-725-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-545-8800",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "ANDA076772"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "62037-725",
     "62037-734",
     "62037-726",
     "62037-727"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210"
    ],
    "spl_id": [
     "24aa9277-3773-489d-8459-f9215140c53f"
    ],
    "spl_set_id": [
     "85ef422d-af27-4126-9841-6892af1871d6"
    ],
    "package_ndc": [
     "62037-725-01",
     "62037-734-01",
     "62037-726-01",
     "62037-727-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "57664-607-88",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-818-4555",
   "availability": "Unavailable",
   "related_info": "Currently not marketed",
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-098-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-098",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-097",
     "68025-084"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-084-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-084",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-097",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-700-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-700",
     "13811-711"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2605796",
     "2605798"
    ],
    "spl_id": [
     "ba649db4-df0d-4587-8370-3f866e66e54b"
    ],
    "spl_set_id": [
     "dd8d7b6e-c23d-4e16-bb53-959e9127ebc6"
    ],
    "package_ndc": [
     "13811-711-30",
     "13811-700-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "50458-585-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021121"
    ],
    "brand_name": [
     "CONCERTA"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-585",
     "50458-588",
     "50458-586",
     "50458-587"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091157",
     "1091170",
     "1091172",
     "1091185",
     "1091187",
     "1091210",
     "1091212"
    ],
    "spl_id": [
     "64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"
    ],
    "spl_set_id": [
     "1a88218c-5b18-4220-8f56-526de1a276cd"
    ],
    "package_ndc": [
     "50458-585-01",
     "50458-588-01",
     "50458-586-01",
     "50458-587-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-095-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-095",
     "68025-088",
     "68025-089",
     "68025-096",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62175-313-37",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA091695"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "62175-313",
     "62175-310",
     "62175-311",
     "62175-312"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2001564",
     "2001565",
     "2001566",
     "2001568"
    ],
    "spl_id": [
     "8b133cd2-e3c6-4742-b402-2393b56ffc93"
    ],
    "spl_set_id": [
     "3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"
    ],
    "package_ndc": [
     "62175-310-37",
     "62175-311-37",
     "62175-312-37",
     "62175-313-37"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-095-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-095",
     "68025-088",
     "68025-089",
     "68025-096",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-711-30",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-711",
     "13811-700"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2605796",
     "2605798"
    ],
    "spl_id": [
     "ba649db4-df0d-4587-8370-3f866e66e54b"
    ],
    "spl_set_id": [
     "dd8d7b6e-c23d-4e16-bb53-959e9127ebc6"
    ],
    "package_ndc": [
     "13811-711-30",
     "13811-700-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-098-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-098",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-097",
     "68025-084"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "50458-586-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021121"
    ],
    "brand_name": [
     "CONCERTA"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-586",
     "50458-585",
     "50458-588",
     "50458-587"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091157",
     "1091170",
     "1091172",
     "1091185",
     "1091187",
     "1091210",
     "1091212"
    ],
    "spl_id": [
     "64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"
    ],
    "spl_set_id": [
     "1a88218c-5b18-4220-8f56-526de1a276cd"
    ],
    "package_ndc": [
     "50458-585-01",
     "50458-588-01",
     "50458-586-01",
     "50458-587-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "57664-608-88",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-818-4555",
   "availability": "Unavailable",
   "related_info": "Currently not marketed",
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62037-727-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-545-8800",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA076655"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "62037-727",
     "62037-725",
     "62037-734",
     "62037-726"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210"
    ],
    "spl_id": [
     "24aa9277-3773-489d-8459-f9215140c53f"
    ],
    "spl_set_id": [
     "85ef422d-af27-4126-9841-6892af1871d6"
    ],
    "package_ndc": [
     "62037-725-01",
     "62037-734-01",
     "62037-726-01",
     "62037-727-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "57664-609-88",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-818-4555",
   "availability": "Unavailable",
   "related_info": "Currently not marketed",
   "update_date": "08/05/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)",
   "company_name": "Sun Pharmaceutical Industries, Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62037-734-01",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA076772"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "62037-734",
     "62037-725",
     "62037-726",
     "62037-727"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210"
    ],
    "spl_id": [
     "24aa9277-3773-489d-8459-f9215140c53f"
    ],
    "spl_set_id": [
     "85ef422d-af27-4126-9841-6892af1871d6"
    ],
    "package_ndc": [
     "62037-725-01",
     "62037-734-01",
     "62037-726-01",
     "62037-727-01"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-706-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "ANDA205327"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-706",
     "13811-709",
     "13811-707",
     "13811-708",
     "13811-710"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461"
    ],
    "spl_id": [
     "0944cf70-d59a-483b-9698-e96ef955a65a"
    ],
    "spl_set_id": [
     "c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"
    ],
    "package_ndc": [
     "13811-709-10",
     "13811-706-10",
     "13811-707-10",
     "13811-708-10",
     "13811-710-10",
     "13811-710-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-097-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-097",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-096",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "68025-096-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA216117"
    ],
    "brand_name": [
     "RELEXXII"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Vertical Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "68025-096",
     "68025-088",
     "68025-089",
     "68025-095",
     "68025-097",
     "68025-084",
     "68025-098"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461",
     "2052826",
     "2605796",
     "2605798",
     "2605943",
     "2605946",
     "2668496",
     "2668499",
     "2668502",
     "2668505"
    ],
    "spl_id": [
     "86f477e9-07fc-466b-913e-1a4434c91df4"
    ],
    "spl_set_id": [
     "22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"
    ],
    "package_ndc": [
     "68025-088-30",
     "68025-089-30",
     "68025-095-10",
     "68025-095-30",
     "68025-096-10",
     "68025-096-30",
     "68025-097-10",
     "68025-097-30",
     "68025-084-30",
     "68025-098-10",
     "68025-098-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)",
   "company_name": "Vertical Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62175-311-37",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA091695"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "62175-311",
     "62175-310",
     "62175-312",
     "62175-313"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2001564",
     "2001565",
     "2001566",
     "2001568"
    ],
    "spl_id": [
     "8b133cd2-e3c6-4742-b402-2393b56ffc93"
    ],
    "spl_set_id": [
     "3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"
    ],
    "package_ndc": [
     "62175-310-37",
     "62175-311-37",
     "62175-312-37",
     "62175-313-37"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "13811-708-10",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "800-541-4802",
   "availability": "Limited Availability",
   "related_info": "Allocation to current contracted customers",
   "openfda": {
    "application_number": [
     "ANDA205327"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Trigen Laboratories, LLC"
    ],
    "product_ndc": [
     "13811-708",
     "13811-709",
     "13811-706",
     "13811-707",
     "13811-710"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1091155",
     "1091170",
     "1091185",
     "1091210",
     "1995461"
    ],
    "spl_id": [
     "0944cf70-d59a-483b-9698-e96ef955a65a"
    ],
    "spl_set_id": [
     "c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"
    ],
    "package_ndc": [
     "13811-709-10",
     "13811-706-10",
     "13811-707-10",
     "13811-708-10",
     "13811-710-10",
     "13811-710-30"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)",
   "company_name": "Trigen Laboratories, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/26/2023",
   "package_ndc": "62175-312-37",
   "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
   "contact_info": "844-834-0530",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA091695"
    ],
    "brand_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "generic_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Lannett Company, Inc."
    ],
    "product_ndc": [
     "62175-312",
     "62175-310",
     "62175-311",
     "62175-313"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "METHYLPHENIDATE HYDROCHLORIDE"
    ],
    "rxcui": [
     "2001564",
     "2001565",
     "2001566",
     "2001568"
    ],
    "spl_id": [
     "8b133cd2-e3c6-4742-b402-2393b56ffc93"
    ],
    "spl_set_id": [
     "3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"
    ],
    "package_ndc": [
     "62175-310-37",
     "62175-311-37",
     "62175-312-37",
     "62175-313-37"
    ],
    "unii": [
     "4B3SC438HI"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)",
   "company_name": "Lannett Company, Inc.",
   "status": "Current"
  }
 ]
}